Can a patient take Frova (frovatriptan) and rizatriptan for migraines together?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Frovatriptan and Rizatriptan Be Taken Together for Migraines?

No, frovatriptan (Frova) and rizatriptan should not be taken together on the same day for migraine treatment. 1

Critical Safety Concern: Triptan Spacing Requirements

  • Triptans should never be combined or taken within 24 hours of each other due to the risk of additive vasoconstrictive effects and potential cardiovascular complications. 1, 2

  • Both frovatriptan and rizatriptan are serotonin 5-HT₁B/1D receptor agonists that work through the same mechanism—causing vasoconstriction of intracranial blood vessels. 3, 4

  • Taking two triptans together or in close succession increases the risk of coronary vasospasm, myocardial ischemia, and other serious cardiovascular events. 5

Appropriate Use of Multiple Triptans

  • If one triptan fails for a particular attack, you may try a different triptan for the next migraine attack (not the same attack), as failure of one triptan does not predict failure of others. 2

  • For the current migraine attack, if the first triptan dose is ineffective after 2 hours, you may take a second dose of the same triptan (not a different one), respecting maximum daily dosing limits. 5

  • Rizatriptan maximum: 30 mg per 24 hours (three 10-mg doses or six 5-mg doses). 4, 6

  • Frovatriptan maximum: 7.5 mg per 24 hours (three 2.5-mg doses). 3

Alternative Strategies When Initial Triptan Fails

  • Add an NSAID to the triptan rather than switching to a different triptan—combination therapy with a triptan plus NSAID (naproxen 500 mg or ibuprofen 400-800 mg) provides superior efficacy compared to either agent alone. 2, 7, 5

  • Consider adding acetaminophen 1000 mg to the triptan, which also shows directionally favorable effects compared to triptan monotherapy. 7

  • Use an antiemetic (metoclopramide 10 mg or prochlorperazine 10 mg) for synergistic analgesia and nausea relief. 2

Medication-Overuse Headache Prevention

  • Limit all acute migraine medications to no more than 2 days per week to prevent medication-overuse headache, which paradoxically increases headache frequency. 1, 2, 7

  • If needing acute treatment more than twice weekly, preventive therapy should be initiated immediately with agents like erenumab, fremanezumab, galcanezumab, topiramate, or propranolol. 1, 8

Choosing Between Frovatriptan and Rizatriptan for Future Attacks

  • Rizatriptan 10 mg provides faster pain relief (peak concentration at 2.3 hours, terminal half-life 3.2 hours) and higher rates of pain freedom at 2 hours compared to frovatriptan. 9, 4

  • Frovatriptan 2.5 mg has a longer duration of action (terminal half-life 29.3 hours) and significantly lower recurrence rates within 72 hours, making it preferable for patients with frequent headache recurrence. 3, 9

  • Frovatriptan is better tolerated with fewer adverse events (one versus eight adverse events in head-to-head comparison). 9

  • For moderate-to-severe attacks requiring rapid relief, rizatriptan is more appropriate; for attacks with high recurrence rates or when tolerability is a concern, frovatriptan is preferable. 3, 9, 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Acute Headache Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute Migraine Treatment.

Continuum (Minneapolis, Minn.), 2015

Research

Rizatriptan in the treatment of migraine.

Clinical therapeutics, 1999

Guideline

Rizatriptan Combination Therapy for Migraine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication Optimization for Headache Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended dosage of Rizatriptan (Triptan) for treating acute migraine episodes in patients with varying degrees of renal impairment?
What is the recommended dosage of Rizatriptan (maxalt) for adults with migraines?
What is the optimal management plan for a patient with migraines currently taking rizatriptan (Maxalt) 10 mg?
Is Rizatriptan (rizatriptan) effective for treating migraine attacks when taken after symptom onset?
Is rizatriptan (triptan) effective for preventing sleep-induced migraines?
What are the implications and treatment for a patient with severe hypokalemia, with a potassium level of 2.6 mEq/L?
What is the maximum duration a patient can be on Fosamax (alendronate)?
Do I need to test a patient's first-degree relatives for H. pylori infection after a diagnosis, especially if they have a history of gastric cancer or are from a high-risk population?
What is the possible diagnosis and treatment for an elderly female patient with type 2 diabetes mellitus (DMII), hypothyroidism, gastroesophageal reflux disease (GERD), hypercholesterolemia, sleep apnea, and hypertension (Htn), who is taking metformin, levothyroxine, and lisinopril, with laboratory results showing elevated C-reactive protein (CRP), leukocytosis, anemia, impaired renal function, and cyclic fevers every 28-30 days, and has a contraindication to statins?
Should I delay surgery for a patient with acute appendicitis who also presents with a cough and rales, indicating potential respiratory compromise?
What is butalbital, specifically in the context of treating migraines and tension headaches in a patient with a history of migraines?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.